Search articles by title, topic or section.
Khabre desk
Recent reporting, analysis and explainers from the FDA desk.
health
A cross-sectional study of 6,308 summary reports in the FDA’s MAUDE database found frequent reporting errors, missing device-problem detail and delays. The reports covered 159,503 adverse events from July 2019 to June 2025.
health
The FDA has authorized Abbott's Libre Duo 10 Day system for people aged 2 years and older with diabetes, allowing continuous glucose and ketone monitoring from a single wearable sensor.
health
The FDA has approved once-daily brepocitinib tablets for adults with dermatomyositis, based on a phase 3 trial that showed better disease-control scores than placebo.